FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Diazepam from Hikma Pharmaceuticals USA Inc. under an ANDA, reflecting a regulatory action on the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Epilepsy
• Insomnia
• Muscle Spasms

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)